Advertise
NEWSLETTER
Serina advances SER-252 Par...
FDA accepts review for Nano...
MetaVia data show DA-1726 c...
Coya’s combination dr...
Alzheon reports Phase 3 win...
Serina advances SER-252 Par...
FDA accepts review for Nano...
MetaVia data show DA-1726 c...
Coya’s combination dr...
Alzheon reports Phase 3 win...
Gene editing
Gene editing CRISPR

Gene-editing tool can programme cuts over time

Life Biosciences

Life Biosciences in-licenses IP from new studies

$85m funding for epigenetic platform technology

Omega Therapeutics secures $85m to carry out clinical trials into epigenetic treatments for five key disease

Oisin

Promising restorative therapy potentially 5 years away

Turn Bio announce worldwide IP for mRNA tech

Using optogenetics on gut microbes can promote Longevity.

Gut health shines a light on Longevity

64x Bio will use proprietary platform to spearhead cell and gene therapy manufacture and to treat age-related diseases.

Viral vector start-up aims to tackle gene therapy Longevity bottleneck

Reducing waiting lists and treating diabetes – eGenesis progesses xenotransplantation without the paradox.

eGenesis advances xenotransplantation research

Cellular stochasticity and epigenetic drift in aging can provide Longevity targets and also provide insights into the origins of cancer.

A novel approach to aging – epigenetics and cellular variability

eGenesis

eGenesis progresses xenotransplantation toward type 1 diabetes

Epigenetic regulation of protein homeostasis following DNA damage

Epigenetic reprogramming

Epigenetic reprogramming: the road to reversing time

Zoltan Istvan announces candidacy for US President, with aging society a key concern

Exclusive: Interview with US presidential candidate

New CRISPR-free gene-editing tool exploits bacterial warfare

UK start-up Ervaxx targets 'dark antigen' genes

Ervaxx exits stealth mode with $17.5 million

eGenesis' groundbreaking xenotransplantation work with Massachusetts General Hospital is to be expanded through additional collaboration.

eGenesis’ xenotransplantation trials move closer to in-human

The Wyss Institute at Harvard is joining forces with Swiss Biotech Cytosurge in a bid to improve CRISPR-based multiplexed gene editing with a single-cell nano-manipulation technology

Wyss Institute and Cytosurge collaborate on CRISPR tech

BioViva to spin out its R&D and bioinformatics

stem cell Yamanaka "bath"

Reprogram, rejuvenate, rewind: spinout

Cytosurge

Better, faster, stronger CRISPR

Dr. Aric Rogers MDI Labs

Fishing for regenerative therapies

Longevity Technology CRISPR Cancer

Human CRISPR trial heralds Longevity success

Cavalier King Charles Spaniel

Rejuvenate Bio teaches old dogs new tricks

23&Me

23andMe redundancies: DNA test market decline?

Ageotype: Four new types of biomarker

Ageotype: Four new types of biomarker

UK Gov releases human germline editing brief

UK Gov releases human germline editing brief

Healios NK cells

Healios bets on natural born killers

CRISPR

CRISPR in-body gene revolution gets underway

Healios KK will use the upcoming JP Morgan Healthcare Conference and Biotech Showcase in CA to highlight its innovative approach to regenerative medication.

Healios to fast-track pluripotent stem cell therapy

CRISPR-Cas9 is currently the most widely used genome editing method. It is a reliable tool to make targeted changes to the genome of living cells.

Primetime for more powerful CRISPR tech

A machine learning tool could be key to the future of gene therapy delivery, following latest research at the Wyss Institute at Harvard.

Machine learning and fast track gene therapy

Genetic discoveries: Implications for Longevity therapies

Genetic discoveries: Implications for Longevity

Identification of rare DNA variants might flag up individuals at high risk of cardiac death before any symptoms appear

Gene test predicts sudden cardiac death

Vertex/CRISPR therapy research signals landmark

Vertex/CRISPR therapy: Longevity landmark?

Top lawyer highlights concerns raised by expected growth in genome editing sector

Gene editing: “fear and excitement in equal measure”

Prime Editing CRISPR

Prime editing set to take slice from CRISPR

Jamie Metzl talks to Longevity.Technology about his new book Hacking Darwin

Hacking Longevity: Exclusive with Jamie Metzl

CRISPR gene editing has made headlines for all the right – and the wrong – reasons. Despite the hyperbole, concerns have been raised about CRISPR

Researchers pin Longevity hopes on new CRISPR gene editor

Scientists from Moscow and Harvard research groups find 17 different genetic interventions that extend life.

Genetic biomarkers for Longevity discovered

Understanding pluripotency – how it is activated and how to harness its power – has great potential for Longevity applications.

Link found between telomeres and pluripotent stem cells

Breakthrough by Stanford University researchers reverses brain decline by disabling a unique molecule to improve cognitive healthspan.

Unique molecule discovered that reverses memory loss

The latest longevity science, investment, innovation and insight, delivered every morning.

This field is hidden when viewing the form